Presented by The Coalition to Strengthen America’s Healthcare{beacon} Health Care Health Care   The Big Story PhRMA warns ...

President Trump's executive order on drug pricing caused a surprising rally in pharmaceutical stocks. Read my analysis of PJP ...

President Trump's bombshell executive order aimed at lowering U.S. drug prices is a step toward a worst-case scenario for the ...

Earnings Estimate Revisions for Astellas Pharma This company is expected to earn $0.82 per share for the fiscal year ending March 2026, which represents a year-over-year change of -24.8%.

As the threat of pharma import tariffs in the U.S. sparks a domestic investment boom, the trend is stirring up criticism of the pharma status quo in Europe, where the same medications often sell ...

The pharmaceutical industry has been left in a ... “As it stands, pricing controls mean that certain US-made drugs are already not available in the UK.” However, pricing controls alone cannot ...